课题基金 / 基金详情

STAT in TNF alpha induced Apoptosis

STAT in TNF alpha induced Apoptosis
STAT 在 TNF α 诱导的细胞凋亡中的作用
批准号:
6812631
负责人:
Y. Eugene Chin
金额:
$24.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2005-02-28

项目摘要

项目成果

Y. Eugene Chin的其他基金

相似基金

相关文献

中文摘要
翻译
肿瘤坏死因子-α(TNFa),一种多效性细胞因子 从激活的巨噬细胞和其他细胞中,在一些 炎症性、心血管和全身疾病。TNFa是一种潜在的 抗癌剂。然而,TNFa对细胞有双重但相反的作用 生长/存活:抑制某些癌细胞的生长并诱导其凋亡 而是刺激其他动物的生长并维持它们的生存。通过绑定到其细胞 表面受体(TNFR1/TNFR2),TNJFa可引发多种信号事件 包括激活Caspase级联和核因子-kB。Caspase激活或 该通路的一个组成部分(S)的过度表达通常会导致细胞凋亡。在……里面 相比之下,核因子-KB的激活对于促进细胞存活和 抑制细胞凋亡。因此,细胞上的TNFa产量由余额决定 核因子-kB和半胱氨酸氨基转移酶激活之间的关系。要触发细胞凋亡,TNFa不仅需要 以激活Caspase,但也可以最小化甚至关闭NF-KB的激活。 关于TNFa如何在触发时抑制核因子-xB的激活,人们知之甚少 半胱氨酸酶的激活。蛋白质酪氨酸磷酸化在信号转导中的作用 许多细胞因子的转导已被证实,但仍不清楚 TNFa。JAK(Janus Kinase)-STAT(信号转导和激活因子) 转录)途径是酪氨酸磷酸化-信号通路,由 干扰素和其他细胞因子。有几条证据表明JAK/STAT 可能在TNFa的信号转导事件中发挥重要作用。第一,肿瘤坏死因子受体 招募JAK/STATI,特别是在对TNFa敏感的细胞中。其次,Jaki-和 STATI缺乏的细胞对TNFa产生抗性。第三,TNFR1信号转接器 与TRANDD共转染致敏TRAND基因诱导的细胞凋亡 斯塔蒂。这些发现导致了以下工作假说:phosphStati是 与TNFR1/Tradd复合体相关的信号适配器。它支持由TNFa诱导的 稳定死亡信号复合体的形成和抑制细胞死亡 核因子-kB的激活及其后续的基因调控。在拟议的研究中, 利用这一新信息的具体目标如下:(1) TNFR介导的JAK/Stat 1激活及STATI作为信号转接子的作用 在死亡过程中,我们将研究信号转导。(2)中美之间的互动 STATI和TRADD在稳定死亡信号复合体中的作用(TNFR1-TRADD-FADD) 将对队形进行分析。(3)STATI对核因子-KB介导的抑制作用 基因调控将进一步探索。这些免费的方法将 STATI在TNA和MAGE诱导细胞凋亡中的基础作用 最终为癌症治疗提供助力。
英文摘要
Tumor necrosis factor-a (TNFa), a pleiotropic cytokine derived from activated macrophages and other cells, plays pivotal roles in some inflammatory, cardiovascular, and systemic diseases. TNFa is a potential anticancer agent. However, TNFa has dual but opposing effects on cell growth/survival: it inhibits growth and induces apoptosis in some cancer cells but stimulates growth and maintains survival in others. By binding to its cell surface receptors (TNFR1/TNFR2), TNJFa elicits several signaling events including activation of the Caspase cascade and NF-KB. Caspase activation or over-expression of a component(s) of this pathway often leads to apoptosis. In contrast, NF-KB activation is critical for promoting cell survival and suppressing apoptosis. Thus, TNFa's output on cell is decided by the balance between NF-KB and Caspase activation. To trigger apoptosis, TNFa needs not only to activate Caspases but also to minimize or even shut down NF-KB activation. Little is known about how TNFa suppresses NF-xB activation while triggering Caspase activation. The role of protein tyrosine phosphorylation in signal transduction has been confirmed for many cytokines but remains unclear for TNFa. The JAK (Janus kinase)-STAT (signal transducer and activator of transcription) pathway is a tyrosine phosphorylation-signaling route used by interferon and other cytokines. Several lines of evidence suggest that JAK/STAT may play an important role in TNFa's signaling events. First, TNF receptors recruit JAK/Stati especially in TNFa-sensitive cells. Second, both Jaki- and Stati-deficient cells become TNFa resistant. Third, TNFR1 signaling adapter TRADD transfection-induced apoptosis is sensitized by co-transfection with Stati. These findings lead to the following working hypothesis: phosphoStati is a signal adapter associated with TNFR1/TRADD complex. It favors TNFa-induced cell death by stabilizing the death signaling complex formation and inhibiting NF-kB activation and its subsequent gene regulation. In the proposed study, the specific aims are designed to exploit this new information as follows: (1) TNFR-mediated JAK/Stat 1 activation and the role of Stati as a signal adapter in death signal transduction will be examined. (2) The interaction between Stati and TRADD in stabilizing death-signaling complex (TNFR1-TRADD-FADD) formation will be analyzed. (3) The inhibitory role of Stati on NF-KB-mediated gene regulation will be further explored. These complimentary approaches will elucidate the fundamental role of Stati in apoptosis induction by TNa and might eventually provide a boost to cancer therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACETYLATION DEPENDENT STAT3 SIGNALSOME IN LIVER CANCER
  • 批准号:
    8359718
  • 项目类别:
  • 资助金额:
    $5.18万
  • 财政年份:
    2011
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
ACETYLATION DEPENDENT STAT3 SIGNALOSOME IN LIVER CANCER
  • 批准号:
    8167905
  • 项目类别:
  • 资助金额:
    $20.69万
  • 财政年份:
    2010
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
Acetylation-Dependent IFN Signal Transduction
  • 批准号:
    7944147
  • 项目类别:
  • 资助金额:
    $29.81万
  • 财政年份:
    2009
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
STAT3 Acetylation and Deacetylation in Metastasis
  • 批准号:
    7234439
  • 项目类别:
  • 资助金额:
    $28.09万
  • 财政年份:
    2005
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: